Historical record - last NADAC publication: 1/1/2019
Product Information
MEPRON 750 MG/5 ML SUSPENSION is a brand product labeled by GlaxoSmithKline LLC, priced at $6.8952 per ML under NDC 00173054700. Its NADAC has been published 313 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the atovaquone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173054700
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
1/1/2019
Active Ingredients
ATOVAQUONEApproval Type
New Drug (NDA)
FDA Application
NDA020500On Market Since
9/18/1998
Pharmacological Classes
Price Statistics
The NADAC for MEPRON 750 MG/5 ML SUSPENSION has been published 313 times since Nov 28, 2013, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8952 per ML |
|---|---|
| All-time high | $6.8952 (Jan 15, 2020) |
| All-time low | $5.3450 (Nov 28, 2013) |
| Median price | $6.3756 |
| Average price | $6.2541 |
| Largest weekly change | +10.0% (Jan 15, 2014) |
| Weeks tracked | 313 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEPRON 750 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for MEPRON 750 MG/5 ML SUSPENSION, manufactured by GlaxoSmithKline LLC, is $6.8952 per ML (NDC 00173054700), effective Jan 15, 2020.
How has the price of MEPRON 750 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has risen 29.0%. It has been tracked across 313 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEPRON 750 MG/5 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has ranged from a low of $5.3450 (Nov 28, 2013) to a high of $6.8952 (Jan 15, 2020), with a median of $6.3756 per ML.
Are there cheaper alternatives to MEPRON 750 MG/5 ML SUSPENSION?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSP, is $0.7030 per ML — about 90% below MEPRON 750 MG/5 ML SUSPENSION.
Who manufactures MEPRON 750 MG/5 ML SUSPENSION?
MEPRON 750 MG/5 ML SUSPENSION (NDC 00173054700) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification